Ka lāʻau "Glidiab MV": aʻo no ka hoʻohana 'ana, maoli

No ka mea malama Inc o ka lua o ka 'ano o ka mimikō, ma i insulina induces ka? Iecaianoaaiiie o nā lātoma muli ma luna o nā mea i hoʻohana gliclazide. Kēia waiwai He He sulfonylurea derivative pili ana i ka lua o ka hanauna.

General ano

Medicine "Glidiab MB 30" ua manaoia e ia i ka Lūkini like paha o ka "Diabeton MV" Palani lāʻau. Available Nine-mea lāʻau lapaʻau Plant "Akrikhin" i loko o ka Moscow māhele 'āina.

Ke medicament pili i ka moʻolelo hypoglycemic konohiki ma ka papa palapala ka Hoʻololi 'kala. Kala like 'ole kā lākou' ole he keʻokeʻo paha holika paha e kinikini blotches. Papa e hoohalike ai i lalo nā paukūʻolokaʻa me he chamfer.

Consumer AEeAaOA mea he pack. Ua hiki ke komo 30 a me 60 o na papa io pūʻolo helu ma blister papa.

'ole

Haʻalele lāʻau "Diabeton CF" me ka mahele lāʻau o ka 0,060 g. Gliclazide, y me medicament "Glidiab CF"'ālike nui o ka hana 'Oponopono i loko o ka palua lalo, i ka 0,030 g.

Ma AEeOEXAaI tableting nā mea hoʻohui nā hydroxypropylmethylcellulose, aerosilovye nā lātoma, makanekiuma stearate, microcrystalline kelulose.

Aia mea i ka lāʻau "Glidiab" me kaʻike mau kala no ka hana waiwai. Laʻau heluna no papa 0.08 g. O ka gliclazide.

Pehea e holo ai

Pili i ka medicament "Glidiab MV" manual iienuaaaony i ka hana o ka gliclazide i ka lawe stimulation o ka insulina secretion ma β-keena, aia i loko o ka pancreas.

Ma lalo o ka aoao o ka papa insulinosekretornaya mahuahua ha awina o ka monakō koko nā lātoma a me kaʻike ākea nā'aʻaʻa e oi ikepili koʻikoʻi i ka insulina hōmona.

Muscle glycogen, i ka intracellular'ūhū hōʻike oi aku ka hoʻokōʻana. Aia He He ka ho'ēmiʻana o ka wā mawaena, mai ka hoomaka ana mai o ka pono o ka ai, e wehe i hōmona. Hou insulina secretion ma kekahi kakahiaka nui piko mea oko a mai ka'ē aʻe sulfonylurea gliclazide precursors, i lawe wahi i loko o ka lua o ke kahua. Emi postprandial monakō koko.

Ka hoʻomaikaʻi microcirculation ia lŘlŘ ma ka hoʻohuiʻia i ka platelet mea pīlali, a aeea normalizing vascular permeability, a hōʻemi ai? Acaeoey o atherosclerotic mikrotromboznyh keʻano o ka hanaʻana, i ka ka ho'ēmiʻana reactions o maoli noho male 'ana o ke koko clots. Ua hoʻemi hana e pane mea loaʻa nā hale i loko o ka ipu koko i loko o ka adrenaline lātoma.

Ka lāʻau 'ke' ūlōlohi mai ana i ke ano diabetic retinopathy ke kahua, ka nonproliferative ma. Hooloihi ae i lapaʻau hope paha, e like me na olelo o ka diabetic hakuʻala poho aha māhele kuleana no ka kānana, ka mea,ʻo ia ka mea e hiki ai ia me ka nui loa emi i ka excretion o ke kumuʻiʻo ma ka mimi.

Ka lāʻau 'Aʻole i hoʻonui i ka kaumaha o ke kino, akā, ma ka mea ku ole, emi aie a hiki i ka hopena ma luna o ke kakahiaka nui kahua o ka insulina kala. Mea, aole ia i hoʻonāukiuki loa insulinemia.

no ke aha pili

Kauka waiho aku i ka hoʻohana 'ana i ka lāʻau a me ka kōpaʻa kiʻekiʻe i loko o ke koko o ka lua o ka degere. Lapaʻau ua lawe mai me ka iki ia ma kaʻai a me ka lōpū physical aayoaeuiinoe.

E medicament "Glidiab CF" nāʻikepili pili me ka Kāohiʻana o ka mea hōʻemi i loko o diabetic kāna hana wehewehe aku nephropathy, retinopathy, myocardial infarction a me ka hahau ana.

Pehea e hoʻohana

Ke dosing loa ua koho no kēlā me kēia hoomanawanui pākahi, mai hoike ana o ka maʻi, i ka lehulehu o ka monakō koko i ka nele opu, a ma hope o 120 minuke ma hope o ka palaoa hokii.

No ka ai ' "Glidiab MV" aʻo ma o ka palapala noi waihona loiloi mua kela la i keia mahele lāʻau o 0,03 g., I mea like me kekahi papa. He lehulehu ua hōʻike ma mua hoʻomanawanuiʻana ma hope o ka makahiki o 65. Ka lapaʻauʻia hoʻohana hōʻike waha kekahi papa i ke kakahiaka, i ka wa aina kakahiaka.

Inā pono, ka laʻau heluna ua mahuahua kela mau pule. Ke i kā mākou ia i ka lā hoʻokahi, e lawe ma kahi o 0,120 g., E like me 4 na papa.

Ka medicament "Glidiab CF" Ua hoʻohana 'ia ma kahi o ka hookahi inoa me kaʻike mau hookuu ka lapaʻauʻia, ka hoʻohana' ana 1-4 papa no ka lā.

Kona hui me nā mea hypoglycemic hana biguanide, alpha-glucosidase inhibitor o ka insulina nā lātoma.

I kaʻaʻa puʻuwai kāna hana hana nawaliwali paha lōpū ano, i ka wa o ka uku o ka creatinineʻae emi o 0.080 nā lika no minuke, aʻaʻole emi i ka dosing.

Ka wā e hiki ole lawe

Papa "Glidiab MV" manual hoi, a kuka, e hoʻohana i ke ano mua o ka mimikō diabetic maʻi ma kiekie ketones i loko o ka mimi, paresis gastric ma hyperosmolar diabetic coma a me ka precoma no ka nui surgeries, a kuni i ka mea nā palapū, traumatic keʻano o ka hanaʻana i ka wa pono i ka insulina lapaau.

Contraindications: loa kāna hana o ke akepaʻa a me nā konāhua functioning, na naau oʻu iaʻi, hoʻololi i ke omo o ka ai, no ka hooulu ana o ka hypoglycemic kulana.

Oe hiki ole hoʻohana i loko o nā mea maʻi me ke kuni, leukopenia, hāpai keiki, umauma-e ai ana a me ka excessive intolerance o nā mea hoʻohui, ka ai '.

Mālama nui ua koi 'ia ka wā lawelawe iho la no ka lapaʻauʻia, kūikawā a me nā koho o nā dosages i ka hoʻomanawanuiʻana, ka poe i ka waiʻona kaukaʻi a me ka hahaki pinepine i loko o ka thyroid gland.

Hiʻona o ka lapaʻau

Ma ka lāʻau "Glidiab MV" aʻo i nā maka i ka pono, e hui pu iho la ia me ka haʻahaʻa-calorieʻai ai ec i ka haʻahaʻa carbohydrate maʻiʻo. Ua pono maʻamau ka mālamaʻana o ka lehulehu o ka monakō koko i loko o ka koko i loko o ke kakahiaka, ma mua a ma hope o ka palaoa.

Inā 'oe iʻoki kino a me decompensation o ka diabetic ana, paha i ka hoike o ke insulina' o ia hoʻi.

Aia olelo ao gipoglikemichekogo kaʻina ia lŘlŘ ma o ka hoʻohana o'eto ka waiʻona, he pili-steroidal Anati-hoʻoʻino Agena a me ka wa e kaawale aku o ka mana. Inu waiʻona hiki i disulfiramopodobnyh maʻi pale, a me aching poo a me ka abdomen, nausea a me ka luaʻi.

He mea pono e hoʻomaʻa i ka laʻau heluna o ka lapaʻauʻia i loko o ke kino a me ka 'ehaʻeha o stress a me ka untimely ai.
No ikepili koʻikoʻi i na ona o ka mea e nā kūpuna, nā mea maʻi me ka'ōpaha paha no kou kino, debilitated e hoomanawanui i ka poe e ae, mai deficiency o adrenal-pituitary kahua.

Ma nā kahua o ka hoʻonaʻauao loiloi mua o ke noi ana o ka lāʻau i loko o ke koho o ka laʻau heluna, ina he mea kekahi predisposition i hypoglycemic hoʻoponopono ulia, ia mea,ʻaʻole e pono ke hana hana i ka pono, a mahuahua nui noonoo ana a me ka kokololio psychomotor reactions.

Adverse reactions

Ka lilo ana o "Glidiab MV" aʻo mai nā 'ike ma luna aʻe' ana i loko o ka endocrine nā loko ma ka hoʻokō 'ole' ma ka papa 'ano, e pono ai, a no kou kino. Nui, ka ho'ēmiʻana o ka monakō koko i loko o ka koko ke kumu o ka hanana o ke poo eha, luhi, pololi, helplessness, uunu nui i instantaneous hoʻonāwaliwaliʻia, aggression, ilihune lehulehu, depressive moku'āina. No hoi, aia no na loli o ka pilikia makapō pokole, tremor, nano a me convulsive kāna hana, pōniuniu, gipersomniyai, pāpaʻu hanu, ua hoʻemi naau kōmi.

Digestive nā loko paka malfunctions i loko o ka palapala o ka malabsorption, nausea, diarrhea, nele o ka ikaika loa ka makemake anorexic, kāna hana o functioning akepaa keena, cholestatic jaundice, hoomahuahua i ka ka hoʻokōʻana o ka transaminase nā'ūhū.

Undesirable keʻano o ka hanaʻana i loko o ka hematopoietic'ōnaehana pili me ka emi ma ka hemoglobin a me ka leukocyte helu platelet keena.

Ka lāʻau 'hiki i allergic reactions i loko o ka palapala o ka ohane, urticaria, makulo-papular wikiwiki.

excessive hoike

Pili i kekahi mea "Glidiab MV" aʻo ma ka cautions e ku e ka overdose, i kaheaia ma ka ke emi ma ka wai koko monakō koko lehulehu. Inā he ikaika loa ka lapaʻauʻia e hoʻomōhala hypoglycemic coma.

E hoʻopau ua haawiia mai i kekahi kanaka iki i kaʻai maikaʻi ke kemu hydrocarbons, no kekahi laʻana, he apana o ke kōpaʻa. A hiki i ke kanaka mea unconscious, oia hoʻolauna i loko o ka aa koko 40 pakeneka dextrose a monakō koko pāʻoihana a me inject i loko o ka Muscle o ka glucagon i loko o ka nui o ka 1 mg. Inā ka hoʻomanawanui mea ala, a laila, ua puʻe wale akula kēlā i kaʻai maikaʻi ke kemu hydrocarbons e pale hou hypoglycemic hoouka.

Ka hui malu pu ana me ka lapaʻauʻia

Ke hypoglycemic ha awina o ka medicament "Glidiab CF 30 mg" hiki ke hoʻokāʻoi 'ia e laua retarder i hoʻolaunaʻia ma angiotensin hoʻololi ''ūhū a me ka Monoamine oxidase type mea loaʻa blocker me ka ho okumu Hoʻokolohua adrenozavisimyh a me h2 gistaminozavisimyh ma muli cimetidine, a me flukonazolovyh mikonazolovyh antifungal ai ', ole-steroidal Anati-hoʻoʻino Luna phenylbutazone, indomethacin, diclofenac.

Ke kanawai o ka mahuahua waiū papa hoʻohana clofibrate a me ka bezafibrate, ethionamide antitubercular ai 'mai ka pae ana o salicylates,ʻauhau'ēʻaʻe anticoagulant i huiʻia o ka coumarin' ole, anabolic steroid, cyclophosphamide, chloramphenicol, sulfonamides me ka hooloihi ae i hopena.

Ka lāʻau 'ka pono emi kō i loko o ke koko wai koko ma ka hoʻohana' ana i blockers o omo excretion,'eto ka waiʻona, acarbose, he biguanide, insulina.

Hoemiia hypoglycemic papa kanawai i barbiturates, lapaau ma muli epinephrine, clonidine, terbutaline, ritodrine, salbutamol, a hiki phenytoin, nā mea kūpale o carbonic anhydrase'ūhū type acetazolamide, thiazide diuretics, hormones o ka thyroid gland, likiuma-na ai ', estrogen laau.

'eto waiʻona lātoma ke ho ololi i ka muli o gliclazide disulfiramopodobnyh kaʻina.

Papaʻeleu ke keʻena ma o na la untimely depolarization a ventricular myocardial nani loa nāʻiʻo ka wā hui me cardiac glycosides.

Hoʻokolohua adrenoblokatornye 'o ia hoʻi klonidinovye, reserpine, guanetidinovye ai' makakiʻi ka lapaʻau hypoglycemia.

Views o nā mea maʻi

Ua ua i pili wale no i ka medicament "Glidiab MV" manual. Reviews olelo e pili ana i mea e hoomanawanui i manaʻo e pili ana i ka laulā o ka lāʻau. Kēia mea paahana kōkua nui nā mea maʻi e emi i ka lehulehu o ka monakō koko i ka maʻamau, a ma ka hui pu ana, me kaʻai EUIAaIN i ke kiʻi o ka hoʻomanawanui ka ola.

People aku nei au i ka maikaʻi hiʻona o ka papa o kona kaawale ana i loko o ke kakahiaka. E like me 'oe hiki ole hoomanao i ka pono no ka lapaau i ka lā.

Ma lapaau "Glidiab MV" hōʻike manaʻo hiki ke lohe, a me ka hopena maikaʻi ano pili me ka ineffectiveness o keia mea paahana. IeAUPIIe, IAa IO kēia ka hana i ka wa a ka hewa dosing ka wā iʻuʻuku nui o ke hoakakaia ka lapaʻauʻia.